RXD Performance — ProShares UltraShort Health Care
Data updated: 2026-08-14
RXD returned +7.84% year to date and −20.51% over one year to May 2026. Annualised returns are −7.12% over 3 years and −6.99% over 5 years. The fund trailed its Trading - Leveraged category average: $100 invested three years ago grew to $80, against $173 for the category, and to $79 over one year, against $137. Volatility over the past three years was 27.40% a year. In the 12 months to May 2026 the fund took in a net $3.5M, and assets reached $5.28M.
RXD Growth of $100
What $100 invested in ProShares UltraShort Health Care grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Trading - Leveraged category average over the same months.
| Period | RXD | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $79 | $137 |
| 3 years (Jun 2023 – May 2026) | $80 | $173 |
| 5 years (Jun 2021 – May 2026) | $70 | $155 |
| Since data start (Sep 2019 – May 2026) | $25 | $181 |
RXD Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +7.84% |
| 1 year | −20.51% |
| 3 years (annualised) | −7.12% |
| 5 years (annualised) | −6.99% |
RXD Annual Returns
Calendar-year total returns of ProShares UltraShort Health Care, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +7.84% |
| 2025 | −21.58% |
| 2024 | +4.87% |
| 2023 | +3.29% |
| 2022 | +0.99% |
| 2021 | −37.94% |
| 2020 | −44.10% |
| 2019 (Sep–Dec) | −22.84% |
RXD Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.4% | −6.4% | +18.6% | +1.1% | −4.4% | — | — | — | — | — | — | — |
| 2025 | −11.8% | −2.3% | +4.2% | +6.4% | +11.4% | −3.3% | +7.0% | −9.5% | −3.0% | −6.3% | −16.2% | +3.3% |
| 2024 | −4.9% | −5.3% | −3.8% | +11.8% | −3.7% | −2.8% | −4.4% | −8.8% | +4.4% | +10.9% | 0.0% | +14.4% |
| 2023 | +3.2% | +10.3% | −3.6% | −5.3% | +10.1% | −7.5% | −1.5% | +2.2% | +7.3% | +7.5% | −9.2% | −7.3% |
| 2022 | +16.2% | +1.3% | −10.5% | +10.3% | −3.5% | +3.7% | −7.2% | +12.2% | +5.4% | −16.5% | −9.1% | +4.3% |
| 2021 | −4.9% | +3.6% | −5.8% | −8.5% | −2.7% | −5.8% | −8.9% | −5.2% | +11.4% | −9.2% | +7.2% | −14.7% |
| 2020 | +5.4% | +12.9% | −7.7% | −24.8% | −8.4% | +2.5% | −10.4% | −4.7% | +2.1% | +6.0% | −15.6% | −7.4% |
| 2019 | — | — | — | — | — | — | — | — | +1.4% | −9.3% | −10.5% | −6.2% |
RXD Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 27.40%
- 3-year Sharpe ratio: -0.42 (vs 4.5% risk-free rate)
- Best month: +18.59% (Mar 2026)
- Worst month: −16.15% (Nov 2025)
RXD Fund Flows
Monthly money in and out of ProShares UltraShort Health Care, from SEC Form N-PORT.
- 12-month net flow: $3.5M
- 12-month gross sales (incl. reinvestments): $5.3M
- Sales ÷ redemptions: 2.87×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $1.2M | $619K | $607K |
| Apr 2026 | $962K | $0 | $962K |
| Mar 2026 | $1.8M | $0 | $1.8M |
| Feb 2026 | $792K | $0 | $792K |
| Jan 2026 | $92K | $176K | −$84K |
| Dec 2025 | $92K | $0 | $92K |
| Nov 2025 | $94K | $0 | $94K |
| Oct 2025 | $0 | $0 | $0 |
| Sep 2025 | $236K | $235K | $736 |
| Aug 2025 | $0 | $591K | −$591K |
| Jul 2025 | $0 | $240K | −$240K |
| Jun 2025 | $0 | $0 | $0 |
RXD Assets Under Management
Net assets of ProShares UltraShort Health Care by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $5.28M |
| 2026-02-28 | $1.71M |
| 2025-11-30 | $978.81K |
| 2025-08-31 | $1.18M |
| 2025-05-31 | $2.15M |
| 2025-02-28 | $1.34M |
| 2024-11-30 | $1.37M |
| 2024-08-31 | $827.74K |
| 2024-05-31 | $774.40K |
| 2024-02-29 | $1.08M |
| 2023-11-30 | $2.08M |
| 2023-08-31 | $1.13M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.